In clinical studies, it has been reported that the levels of plasma apelin were elevated in insulin-resistant subjects [18] and in morbidly obese individuals with type 2 diabetes [19], [20], compared with normal controls. The gene discussed is INS; the disease is type 2 diabetes mellitus.